IMM.ASX

Immutep Limited

Recent research View all research

About Immutep Limited

Prima BioMed Ltd (PRR) is a global biotechnology company headquartered in Australia. PRR focuses on personalised bio-therapeutic products for cancer. Its lead product is CVac, an autologous dendritic cell-based product currently in clinical trials for ovarian cancer patients who are in remission. PRR also develops an oral vaccine against Human Papilloma Virus (HPV).

Forsyth Barr Analyst

Share price performance

All stock prices and news delayed 20 minutes

11:40 August 24th 2019 NZST

0.02 0.0%

0.02 Buy

0.02 Sell

Last 0.02

Open 0.02

High 0.02

Low 0.02

Volume 548,189

Turnover $12,060

Most recent trades All trades for the day

Time Price Volume Value
15:56 0.02 25,000 $550.00
15:53 0.02 350,000 $7,700.00
15:48 0.02 133,189 $2,930.16
10:16 0.02 14,837 $326.41
10:04 0.02 23,100 $508.20

Latest Immutep Limited research

Today's trades

Trade Number Time Price Volume Value
6 15:56 0.02 25,000 $550.00
5 15:53 0.02 350,000 $7,700.00
4 15:48 0.02 133,189 $2,930.16
3 10:16 0.02 14,837 $326.41
2 10:04 0.02 23,100 $508.20
1 10:04 0.02 2,063 $45.39

Latest Immutep Limited news

If you're new to investing or just have a question please call us: 0800 367 227